Litigation

Recent Posts

U.S. Food and Drug Administration Selects LexisNexis Concordance FYI for Real-Time, Anywhere Access to Critical Discovery Data
Posted on 10 May 2012 by LexisNexis Litigation Resource Community Staff

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, has joined the ranks of organizations to select LexisNexis Concordance FYI for real-time, anywhere access to centralized and secure discovery... Read More

Tags: Concordance FYI , discovery , U.S. Food and Drug Administration

Dallas County Listeria Death Leads To Lawsuit Against Cantaloupe Producer, Distributor
Posted on 15 Nov 2011 by LexisNexis Litigation Resource Community Staff

DALLAS - The Listeria attorneys at Marler Clark , the nation's foremost law firm dedicated to representing victims of foodborne illness and Dallas-based law firm Reyes Brown Reilley have filed a lawsuit on behalf of the family of a Dallas woman who... Read More

Tags: Marler Clark , Jensen Farms , FDA , Bill Marler , U.S. Food and Drug Administration , Litigation , lawsuit , Listeria , Centers for Disease Control and Prevention , foodborne illness

Split 6th Circuit Says Graphic Cigarette Pack Warnings Are Constitutional
Posted on 19 Mar 2012 by Michael Lefkowitz

LOUISVILLE, Ky. - (Mealey's) Given that tobacco companies have learned to circumvent bans on marketing to minors, a divided Sixth Circuit U.S. Court of Appeals said March 19, the U.S. Food and Drug Administration's proposal for large, graphic... Read More

Tags: cigarette packs , cigarette warnings , tobacco companies , FDA , smoking , U.S. Food and Drug Administration , Sixth Circuit , 2009 Family Smoking Prevention and Tobacco Control Act , Litigation , amp , Lottery Inc. v. United States of America , First Amendment , Discount Tobacco City &amp , tobacco

Federal Judge Blocks Graphic Cigarette Warnings
Posted on 4 Nov 2011 by Michael Lefkowitz

WASHINGTON, D.C. - (Mealey's) Saying graphic new cigarette pack warnings ordered by the U.S. Food and Drug Administration violate companies' First Amendment rights by compelling speech, a judge in the U.S. District Court for the District of Columbia... Read More

Tags: warning labels , R.J. Reynolds , R.J. Reynolds Tobacco Co. v. U.S. Food and Drug Administration , Zauderer v. Office of Disciplinary Counsel for Sup. Ct. of Ohio , cigarettes , cigarette pack warnings , smoking , U.S. Food and Drug Administration , Litigation , First Amendment , tobacco

FDA Announces Ban On Chinese Company’s ‘Bidi’ Type Cigarettes
Posted on 21 Feb 2014 by Michael Lefkowitz

ROCKVILLE, Md. — (Mealey’s) For what it says is the first time since the Family Smoking Prevention and Tobacco Control Act became law in 2009, the U.S. Food and Drug Administration on Feb. 21 ordered an end to the sale in the United States... Read More

Tags: Sutra Bidis Menthol , Jash International , Family Smoking Prevention and Tobacco Control Act , Sutra Bidis Menthol Cone , cigarettes , FDA , smoking , U.S. Food and Drug Administration , Sutra Bidis Red Cone , Litigation , “bidi” tobacco products , China , Sutra Bidis Red , torts , tobacco

FDA Halts Sale Of 4 Tobacco Products, Says R.J. Reynolds Did Not Comply With Law
Posted on 15 Sep 2015 by James Cordrey

WASHINGTON, D.C. — (Mealey’s) The U.S. Food and Drug Administration announced Sept. 15 that it has issued orders halting the further sale and distribution of four currently marketed R.J. Reynolds Tobacco Co. cigarette products, including its... Read More

Tags: Federal Food , Pall Mall Deep Set Recessed Filter Menthol , cigarettes , Pall Mall Deep Set Recessed Filter , Vantage Tech 13 , U.S. Food and Drug Administration , Litigation , Drug and Cosmetic Act , Camel Crush Bold , torts , R.J. Reynolds Tobacco Co. , tobacco

Glaxo To Plead Guilty, Will Pay $3 Billion Stemming From Drug Marketing
Posted on 2 Jul 2012 by Tom Moylan

BOSTON - (Mealey's) GlaxoSmithKline LLC (GSK) agreed June 2 to plead guilty and to pay $3 billion to resolve broad-ranging criminal and civil allegations in Massachusetts federal court regarding the promotion of several prescription drugs, failure... Read More

Tags: diabetes drug , Lotronex , Wellbutrin , drugs , GlaxoSmithKline LLC , False Claims Act , United States ex rel. Greg Thorpe v. GlaxoSmithKline PLC , Imitrex , Valtrex , Paxil , antidepressants , United States of America v. GlaxoSmithKline LLC , U.S. Department of Justice , U.S. Food and Drug Administration , Litigation , GSK , Flovent , prescription drugs , Avandia

Glaxo Takes $2.36 Billion Charge On Legal Costs
Posted on 15 Jul 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) Pharmaceutical company GlaxoSmithKline said Thursday it expects to take a $2.36 billion charge against second-quarter earnings for the costs of settling court cases over the antidepressant Paxil and diabetes drug Avandia. The company said... Read More

Tags: diabetes drug , European Medicines Agency , birth defects , Paxil , settlements , U.S. Food and Drug Administration , Apotex , Litigation , GSK , GlaxoSmithKline , lawsuit , pharmaceutical , antidepressant , Avandia

AstraZeneca Pays $198M To Settle Seroquel Lawsuits
Posted on 9 Aug 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber . Read More

Tags: drugs , AstraZeneca , drug , antipsychotic , U.S. Food and Drug Administration , Litigation , Nexium , lawsuit , settle , diabetes , Seroquel